Addus HomeCare price target raised to $96 from $92 at Barclays
Barclays analyst Andrew Mok raised the firm's price target on Addus HomeCare to $96 from $92 and keeps an Underweight rating on the shares. The firm adjusted targets among its U.S. healthcare facilities and managed care coverage ahead of Q2 earnings from the group.